Abstract:Pulmonary neuroendocrine tumors (PNETs) can be classified as four variants: typical carcinoid (TC), atypical carcinoid (AC), small cell lung cancer (SCLC) and large cell neuroendocrine carcinoma (LCNEC). Classification of the four tumor categories is a step-wise process identified by the presence of necrosis and number of mitoses per 2mm2. In NE tumor pathology, Ki-67 was first described as prognostic factor in the pancreas and was incorporated into the grading system of digestive tract NE neoplasms in the 2010 World Health Organization (WHO) classification. However, the significance of Ki-67 has not been fully studied in PNETs. The purpose of our research is to investigate the potentially diagnostic value of Ki-67. We retrieved 160 surgical specimens of pulmonary neuroendocrine tumors (37 TC, 2 AC, 30 LCNEC, 91 SCLC) based on mitotic rate and histologic features. A nuclear quantitation algorithm was used to calculate the Ki-67 proliferative index (PI). Six equivalent fields (500 × 500μｍ) at 10× magnification were manually annotated for digital image analysis. The mitotic activity was manually quantitated in the most cellular areas on whole-slide images, eight 40× high power fields were calibrated as 2 mm2. The median mitotic count and Ki-67 index for TC, AC, LCNEC, and SCLC were 1 and 3.96%, 6 and 28.91%, 58 and 57.62%, 118 and 79.3%, respectively. However, the Ki-67 index overlapped among the four groups, with ranges of 0.38-13.49% for TC, 16.34-41.48% for AC, 30.67-93.74% for LCNEC, and 12.43-96.87% for SCLC. The Ki-67 index was positively associated with mitotic number (P<0.001). Neuroendocrine carcinomas can be separated into two groups, high grade (Ki-67＞10％) and low grade (Ki-67≤10％). However, there is no adequate threshold to separate pulmonary AC from TC and no statistic difference of Ki-67 index between LCNEC and SCLC. For the univariate survival analyses in PNETs, both the Overall Survival (OS) and Progression Free Survival (PFS) correlated with Ki-67 index, mitotic number and nodal metastasis. But none of them was proved to be an independent prognostic factor. In high grade PNETs, multivariate analysis revealed that tumor size has a trend of being an independent prognostic factor, but did not reach significant level (P=0.085). Our results indicate that software-automated quantitation of Ki-67 index is a reliable method to predict the prognosis of PNETs. In addition, Ki-67 index can be a useful adjunct to pathologic grade in pulmonary neuroendocrine carcinoma.

The prognostic value of S-100 protein and Ki-67 index in olfactory neuroblastoma

[Clinical Analysis of 10 Cases of Olfactory Neuroblastoma].

Predicting Tumor Recurrence Of Astrocytoma By Ki-67 And Proton Magnetic Resonance Spectra

Clinical and pathological analysis of the olfactory neuroblastoma

Evaluating the prognostic potential of the Ki67 proliferation index and tumour‐infiltrating lymphocytes in olfactory neuroblastoma

Comparison of Tumor Markers for Predicting Disease-Free Survival in Surgically Resected Pancreatic Neuroendocrine Tumors

The relationship between the expression of Ki-67 and the prognosis of osteosarcoma

Prognostic value of Ki-67 index in adult medulloblastoma after accounting for molecular subgroup: a retrospective clinical and molecular analysis

What is the Prognostic Significance of Ki-67 Positivity in Oral Squamous Cell Carcinoma?

Overexpression of S100A2 Protein As a Prognostic Marker for Patients with Stage I Non Small Cell Lung Cancer

Clinical Character and Treatment Evaluation with Olfactory Neuroblastoma and Olfactory Esthesioneoroepithelioma

PUB034 Automated Quantification of Ki-67 Index Associates with Pathologic Grade and Prognosis of Pulmonary Neuroendocrine Tumors

Ki67 Proliferation Index As a Histopathological Predictive and Prognostic Parameter of Oral Mucosal Melanoma in Patients Without Distant Metastases.

The Assessment of Ki-67 for Prognosis of Gastroenteropancreatic Neuroendocrine Neoplasm Patients: a Systematic Review and Meta-Analysis

Modified Histopathological Grading Optimizes Prediction of Survival Outcomes in Small Intestinal Neuroendocrine Tumours

The clinical significance of Ki-67 as a marker of prognostic value and chemosensitivity prediction in hormone-receptor-positive breast cancer: a meta-analysis of the published literature.

Automated Quantification Of Ki-67 Index Associates With Pathologic Grade Of Pulmonary Neuroendocrine Tumors

Prognostic Factors and Outcomes of Multimodality Treatment in Olfactory Neuroblastoma.

Long-Term Prognostic Analysis after Endoscopic Endonasal Surgery for Olfactory Neuroblastoma: A Retrospective Study of 13 Cases.

Prognostic Immunohistochemistry for Ki-67 and OTP on Small Biopsies of Pulmonary Carcinoid Tumors

Prognostic Value of Ki-67 Index in Patients With Endometrial Stromal Sarcoma